Viewing StudyNCT00004260



Ignite Creation Date: 2024-05-05 @ 11:21 AM
Last Modification Date: 2024-10-26 @ 9:04 AM
Study NCT ID: NCT00004260
Status: COMPLETED
Last Update Posted: 2011-08-03
First Post: 2000-01-28

Brief Title: Interleukin-12 Plus Rituximab in Treating Patients With Non-Hodgkins Lymphoma
Sponsor: Mayo Clinic
Organization: Mayo Clinic

Organization Data

Organization: Mayo Clinic
Class: OTHER
Study ID: CDR0000067514
Study Type: None
Study Domain: None
Study Link: None
Lead Sponsor: Mayo Clinic
Lead Sponsor Class: OTHER
Responsible Party: None
Responsible Party Title: None
Responsible Party Type: None
Responsible Party Affiliation: None
Old Name: Stephen Maxted Ansell MD
Old Organization: Mayo Clinic Cancer Center

Collaborators

Name Class
National Cancer Institute NCI NIH